Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Luporini

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD studyA Zaniboni, R Labianca, G Martignoni, et al.
Cancer|November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) reportA Zaniboni, S Barni, R Labianca, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder CancerV Lorusso, C F Pollera, M Antimi, et al.
Oncology|March 1, 1993
A cisplatinum-cyclophosphamide regimen in advanced ovarian cancer: reporting 5-year resultsM C Locatelli, A D'Antona, R Carcione, et al.
Tumori|July 30, 1999
[Adjuvant therapy of colon cancer. State of the art and future perspectives]S Barni, S Cascinu, P Foa, et al.
Journal of Pain and Symptom Management|April 16, 1999
A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative CareM Pirovano, M Maltoni, O Nanni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract CancerS Cascinu, R Labianca, P Alessandroni, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) studyS Cascinu, S Barni, R Labianca, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Chemotherapy (Florence, Italy)|February 1, 1996
Sequential methotrexate and 5-fluorouracil as second-line chemotherapy for advanced colorectal cancer patients pretreated with 5-fluorouracil and leucovorin: a GISCAD studyA Zaniboni, R Labianca, G Martignoni, et al.
Cancer|November 15, 1995
Epirubicin, cisplatin, and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) reportA Zaniboni, S Barni, R Labianca, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Biochemical modulation of fluoropyrimidines: the "GISCAD" studies. GISCAD (Italian Group for the Study of Digestive Tract Cancer)R Labianca, G Pancera, S Barni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder CancerV Lorusso, C F Pollera, M Antimi, et al.
Oncology|March 1, 1993
A cisplatinum-cyclophosphamide regimen in advanced ovarian cancer: reporting 5-year resultsM C Locatelli, A D'Antona, R Carcione, et al.
Tumori|July 30, 1999
[Adjuvant therapy of colon cancer. State of the art and future perspectives]S Barni, S Cascinu, P Foa, et al.
Journal of Pain and Symptom Management|April 16, 1999
A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative CareM Pirovano, M Maltoni, O Nanni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract CancerS Cascinu, R Labianca, P Alessandroni, et al.
British Journal of Cancer|July 17, 1999
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)S Cascinu, R R Silva, S Barni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 1997
Evaluation of factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD) studyS Cascinu, S Barni, R Labianca, et al.
Pageof 6